The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Merlin C. Thomas

Baker IDI Heart and Diabetes Institute

Melbourne

Victoria

Australia

[email]@baker.edu.au

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. 2009
  • Baker Heart Research Institute, Melbourne, VIC. 2003 - 2009
  • Danielle Alberti Memorial Centre for Diabetes Complications, Baker Heart Research Institute, Melbourne, Australia. 2003 - 2007
  • The Baker Heart Research Institute, P.O. Box 6492, St. Kilda Rd. Central, Melbourne, Australia. 2005 - 2007
  • Department of Medicine, Austin and Repatriation Medical Center, Heidelberg, Victoria, Australia. 2003 - 2004
  • Renal Unit, The Queen Elizabeth Hospital, Adelaide, Australia. 2003

References

  1. Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment cO-existing with NIDDM [NEFRON] 11). Thomas, M.C., Macisaac, R.J., Jerums, G., Weekes, A., Moran, J., Shaw, J.E., Atkins, R.C. Diabetes. Care (2009) [Pubmed]
  2. Management of dyslipidaemia in patients with type 2 diabetes in Australian primary care. Thomas, M.C., Nestel, P.J. Med. J. Aust. (2007) [Pubmed]
  3. Anemia in diabetes: marker or mediator of microvascular disease?. Thomas, M.C. Nature Clinical Practice. Nephrology (2007) [Pubmed]
  4. The CARI guidelines. Prevention of progression of kidney disease: early detection of patients with kidney disease. Thomas, M.C. Nephrology. (Carlton) (2007) [Pubmed]
  5. The CARI guidelines. Prevention of progression of kidney disease: early referral of patients with pre-end-stage kidney disease. Thomas, M.C. Nephrology. (Carlton) (2007) [Pubmed]
  6. The CARI guidelines. Prevention of progression of kidney disease: regular and frequent follow-up of patients with pre-end-stage kidney disease. Thomas, M.C. Nephrology. (Carlton) (2007) [Pubmed]
  7. The CARI guidelines. Prevention of progression of kidney disease: pre-dialysis education for patients with chronic kidney disease. Thomas, M.C. Nephrology. (Carlton) (2007) [Pubmed]
  8. The CARI guidelines. Prevention of progression of kidney disease: weight reduction in obese patients with chronic kidney disease. Thomas, M.C. Nephrology. (Carlton) (2007) [Pubmed]
  9. The CARI guidelines. Prevention of progression of kidney disease: autosomal-dominant polycystic kidney disease. Thomas, M.C. Nephrology. (Carlton) (2007) [Pubmed]
  10. The burden of chronic kidney disease in Australian patients with type 2 diabetes (the NEFRON study). Thomas, M.C., Weekes, A.J., Broadley, O.J., Cooper, M.E., Mathew, T.H. Med. J. Aust. (2006) [Pubmed]
  11. The epidemiology of hemoglobin levels in patients with type 2 diabetes. Thomas, M.C., Tsalamandris, C., MacIsaac, R.J., Jerums, G. Am. J. Kidney Dis. (2006) [Pubmed]
  12. Anaemia in diabetes: Is there a rationale to TREAT?. Thomas, M.C., Cooper, M.E., Rossing, K., Parving, H.H. Diabetologia (2006) [Pubmed]
  13. Functional erythropoietin deficiency in patients with Type 2 diabetes and anaemia. Thomas, M.C., Tsalamandris, C., Macisaac, R., Jerums, G. Diabet. Med. (2006) [Pubmed]
  14. The assessment of kidney function by general practitioners in Australian patients with type 2 diabetes (NEFRON-2). Thomas, M.C., Weekes, A.J., Broadley, O.J., Cooper, M.E. Med. J. Aust. (2006) [Pubmed]
  15. The high prevalence of anemia in diabetes is linked to functional erythropoietin deficiency. Thomas, M.C. Semin. Nephrol. (2006) [Pubmed]
  16. Identification of obesity in patients with type 2 diabetes from Australian primary care: the NEFRON-5 study. Thomas, M.C., Zimmet, P., Shaw, J.E. Diabetes. Care (2006) [Pubmed]
  17. Blood pressure lowering for the prevention and treatment of diabetic kidney disease. Thomas, M.C., Atkins, R.C. Drugs (2006) [Pubmed]
  18. Anemia with impaired erythropoietin response in diabetic patients. Thomas, M.C., Cooper, M.E., Tsalamandris, C., MacIsaac, R., Jerums, G. Arch. Intern. Med. (2005) [Pubmed]
  19. Tubular changes in early diabetic nephropathy. Thomas, M.C., Burns, W.C., Cooper, M.E. Advances. Chronic. Kidney. Disease (2005) [Pubmed]
  20. Increased tubular organic ion clearance following chronic ACE inhibition in patients with type 1 diabetes. Thomas, M.C., Jerums, G., Tsalamandris, C., Macisaac, R., Panagiotopoulos, S., Cooper, M.E. Kidney Int. (2005) [Pubmed]
  21. The role of AGEs and AGE inhibitors in diabetic cardiovascular disease. Thomas, M.C., Baynes, J.W., Thorpe, S.R., Cooper, M.E. Curr. Drug. Targets (2005) [Pubmed]
  22. Low-molecular weight advanced glycation end products: markers of tissue AGE accumulation and more?. Thomas, M.C., Forbes, J.M., MacIsaac, R., Jerums, G., Cooper, M.E. Ann. N. Y. Acad. Sci. (2005) [Pubmed]
  23. Interactions between renin angiotensin system and advanced glycation in the kidney. Thomas, M.C., Tikellis, C., Burns, W.M., Bialkowski, K., Cao, Z., Coughlan, M.T., Jandeleit-Dahm, K., Cooper, M.E., Forbes, J.M. J. Am. Soc. Nephrol. (2005) [Pubmed]
  24. Anaemia in diabetes: an emerging complication of microvascular disease. Thomas, M., Tsalamandris, C., MacIsaac, R., Jerums, G. Current. Diabetes. Reviews (2005) [Pubmed]
  25. The burden of anaemia in type 2 diabetes and the role of nephropathy: a cross-sectional audit. Thomas, M.C., MacIsaac, R.J., Tsalamandris, C., Molyneaux, L., Goubina, I., Fulcher, G., Yue, D., Jerums, G. Nephrol. Dial. Transplant. (2004) [Pubmed]
  26. Elevated iron indices in patients with diabetes. Thomas, M.C., MacIsaac, R.J., Tsalamandris, C., Jerums, G. Diabet. Med. (2004) [Pubmed]
  27. The role of advanced glycation in reduced organic cation transport associated with experimental diabetes. Thomas, M.C., Tikellis, C., Kantharidis, P., Burns, W.C., Cooper, M.E., Forbes, J.M. J. Pharmacol. Exp. Ther. (2004) [Pubmed]
  28. Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetes. Thomas, M.C., Tsalamandris, C., MacIsaac, R., Medley, T., Kingwell, B., Cooper, M.E., Jerums, G. Kidney Int. (2004) [Pubmed]
  29. Anemia in patients with type 1 diabetes. Thomas, M.C., MacIsaac, R.J., Tsalamandris, C., Molyneaux, L., Goubina, I., Fulcher, G., Yue, D., Jerums, G. J. Clin. Endocrinol. Metab. (2004) [Pubmed]
  30. Dialysis delayed is death prevented: a clinical perspective on the RENAAL study. Thomas, M.C., Cooper, M.E., Shahinfar, S., Brenner, B.M. Kidney Int. (2003) [Pubmed]
  31. Unrecognized anemia in patients with diabetes: a cross-sectional survey. Thomas, M.C., MacIsaac, R.J., Tsalamandris, C., Power, D., Jerums, G. Diabetes. Care (2003) [Pubmed]
  32. Reduced tubular cation transport in diabetes: prevented by ACE inhibition. Thomas, M.C., Tikellis, C., Burns, W.C., Thallas, V., Forbes, J.M., Cao, Z., Osicka, T.M., Russo, L.M., Jerums, G., Ghabrial, H., Cooper, M.E., Kantharidis, P. Kidney Int. (2003) [Pubmed]
  33. Perioperative blood pressure control, delayed graft function, and acute rejection after renal transplantation. Thomas, M.C., Mathew, T.H., Russ, G.R., Rao, M.M., Moran, J. Transplantation (2003) [Pubmed]
 
WikiGenes - Universities